Romilkimab (Anti-IL-13 & IL-4)
Product Specifications
CAS Number
1399584-78-1
Synonyms
SAR156597
Target
Interleukins
Applications
Immunology & Inflammation
Additionnal Information
Romilkimab is a humanized bispecific immunoglobulin-G4 antibody that targets and neutralizes IL-4 and IL-13, effectively downmodulating the inflammatory response. Its treatment significantly reduces thymus and activation-regulated chemokine (TARC) levels in patients with idiopathic pulmonary fibrosis (IPF) and significantly decreases the modified Rodnan skin score (mRSS) in patients with diffuse cutaneous systemic sclerosis (dcSSc) . MW: 198.16 KD.
Storage Conditions
-80°C (avoid freeze-thaw cycles)
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSH030692 50 µg
Recombinant Human TRP1/TYRP1 Protein (Human Cells, His Tag)
Sign In for Pricing
View Details 
BNC472024-100 1x 100 µL
Tyrosinase (Melanoma Marker) (TYR/2024R), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
